Company page

Novacyt Sas

Novacyt Sas, traded under the ticker ALNOV, is a public company based in France with a market capitalization of approximately €38.2 million. The company is involved in the biotechnology sector, focusing on the development and commercialization of diagnostic solutions. Novacyt aims to provide innovative products that address critical healthcare needs.

ALNOV:EURONEXTUpdated September 5, 2026
Novacyt Sas logo
Ticker
ALNOV:EURONEXT
Asset type
Stock
Market cap
$42.7M
Sector
Health Technology
Industry
Medical Specialties
Exchange
EURONEXT
Currency
EUR